19-42528358-G-A
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 0P and 4B. BP4_Strong
The NM_001712.5(CEACAM1):c.17C>T(p.Ala6Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000362 in 1,613,814 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001712.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CEACAM1 | NM_001712.5 | c.17C>T | p.Ala6Val | missense_variant | 1/9 | ENST00000161559.11 | NP_001703.2 | |
LIPE-AS1 | NR_073180.1 | n.205+43135G>A | intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CEACAM1 | ENST00000161559.11 | c.17C>T | p.Ala6Val | missense_variant | 1/9 | 1 | NM_001712.5 | ENSP00000161559 | P2 | |
LIPE-AS1 | ENST00000594624.7 | n.194+43135G>A | intron_variant, non_coding_transcript_variant | 1 |
Frequencies
GnomAD3 genomes AF: 0.000368 AC: 56AN: 152120Hom.: 1 Cov.: 31
GnomAD3 exomes AF: 0.000331 AC: 83AN: 250936Hom.: 0 AF XY: 0.000295 AC XY: 40AN XY: 135656
GnomAD4 exome AF: 0.000362 AC: 529AN: 1461694Hom.: 1 Cov.: 31 AF XY: 0.000415 AC XY: 302AN XY: 727164
GnomAD4 genome AF: 0.000368 AC: 56AN: 152120Hom.: 1 Cov.: 31 AF XY: 0.000336 AC XY: 25AN XY: 74310
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 16, 2021 | The c.17C>T (p.A6V) alteration is located in exon 1 (coding exon 1) of the CEACAM1 gene. This alteration results from a C to T substitution at nucleotide position 17, causing the alanine (A) at amino acid position 6 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at